Edition:
United Kingdom

Zeria Pharmaceutical Co Ltd (4559.T)

4559.T on Tokyo Stock Exchange

2,307JPY
20 Aug 2018
Change (% chg)

¥-27 (-1.16%)
Prev Close
¥2,334
Open
¥2,315
Day's High
¥2,320
Day's Low
¥2,296
Volume
79,300
Avg. Vol
83,170
52-wk High
¥2,677
52-wk Low
¥1,923

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 14,924.10 4.004
Dec 17,231.90 35.934
Sep 16,442.60 28.565
Jun 15,970.00 12.387
FY 2017 Mar '17 15,806.40 12.626
Dec 16,729.80 16.320
Sep 15,825.20 12.771
Jun 16,488.40 25.012
FY 2016 Mar '16 15,420.50 3.357
Dec 16,710.80 32.352
Sep 15,617.70 13.648
Jun 14,726.00 16.792
 
*Note: Units in Millions ofYen
**Note: Units in Yen

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 37.11 30.93 32.76
P/E High - Last 5 Yrs. 41.76 40.66 45.44
P/E Low - Last 5 Yrs. 15.07 23.69 24.26
Beta 0.43 0.90 0.89
Price to Sales (TTM) 1.66 3.94 5.75
Price to Book (MRQ) 1.74 4.88 5.00
Price to Tangible Book (MRQ) 3.84 5.70 6.57
Price to Cash Flow (TTM) 15.97 22.85 23.29
% Owned Institutions -- 1.23 2.21

Dividends

  Company industry sector
Dividend Yield 1.59 1.57 1.51
Dividend Yield - 5 Year Avg 1.69 1.58 1.52
Dividend 5 Year Growth Rate 8.88 4.35 5.22
Payout Ratio(TTM) 59.15 45.85 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -3.14 2.27 8.01
Sales (TTM) vs TTM 1 Yr. Ago 0.15 4.77 5.64
Sales - 5 Yr. Growth Rate 4.05 9.94 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -50.47 17.61 20.60
EPS (TTM) vs TTM 1 Yr. Ago -27.25 -- --
EPS - 5 Yr. Growth Rate 1.19 9.75 10.66
Capital Spending - 5 Yr. Growth Rate 21.70 15.37 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.64 2.15 2.22
Current Ratio (MRQ) 0.84 2.94 3.03
LT Debt to Equity (MRQ) 4.42 10.03 12.51
Total Debt to Equity (MRQ) 61.09 14.07 16.85
Interest Coverage (TTM) -- 35.77 32.63

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 71.01 54.71 54.37
Gross Margin - 5 Yr. Avg. 70.17 52.10 52.17
EBITD Margin (TTM) 11.19 -- --
EBITD - 5 Yr. Avg 12.60 18.48 10.65
Operating Margin (TTM) 4.80 14.31 4.32
Operating Margin - 5 Yr. Avg. 7.58 14.43 6.06
Pre-Tax Margin (TTM) 6.37 14.80 5.18
Pre-Tax Margin - 5 Yr. Avg. 9.00 14.82 6.49
Net Profit Margin (TTM) 4.51 11.05 1.48
Net Profit Margin - 5 Yr. Avg. 6.24 11.12 2.77
Effective Tax Rate (TTM) 29.17 23.22 23.11
Effective Tax Rate - 5 Yr. Avg. 30.72 23.48 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 36,407,160 952,976,482 860,375,103
Net Income/Employee (TTM) 1,642,619 112,117,219 101,207,184
Receivable Turnover (TTM) 4.00 5.72 5.87
Inventory Turnover (TTM) 2.13 2.63 3.41
Asset Turnover (TTM) 0.56 0.96 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 2.52 11.58 11.13
Return on Assets - 5 Yr. Avg. 3.88 12.95 12.40
Return on Investment (TTM) 4.24 15.07 14.61
Return on Investment - 5 Yr. Avg. 5.72 16.90 16.13
Return on Equity (TTM) 4.61 16.59 16.33
Return on Equity - 5 Yr. Avg. 7.03 17.97 17.39
  1 Year 3 Year 5 Year
Sales % 3.80 1.51 4.05
EPS (TTM) % 0.88 -16.59 1.19
Dividend % 3.23 4.89 8.88
Note: Units in Millions of US Dollars

Performance for Zeria Pharmaceutical Co Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -0.45 -5.97 33 23
13 Week -4.56 -9.09 42 33
26 Week 18.68 4.79 79 28
52 Week 13.06 -9.27 62 12
YTD 11.31 0.19 59 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 26.28%
# of Holders: 62
Total Shares Held: 13,960,958
3 Mo. Net Change: 1,398,219
# New Positions: 4
# Closed Positions: 3
# Increased Positions: 17
# Reduced Positions: 10
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.